Grandiflorenic acid is a diterpenoid carboxylic acid, specifically a labdane-type diterpene, isolated from various plant species, notably within the *Wedelia* genus. It is characterized by its specific pentacyclic structure containing carboxylic acid and olefinic functionalities. This natural product has garnered significant research interest primarily for its potent biological activities. Studies have demonstrated that grandiflorenic acid exhibits notable anti-inflammatory effects, often evaluated through models like carrageenan-induced paw edema. Its mechanism is associated with the inhibition of key inflammatory mediators such as prostaglandins and cytokines. Additionally, it has shown promising cytotoxic activity against several human cancer cell lines, indicating potential as a lead compound for anticancer drug development. As a plant-derived bioactive molecule, grandiflorenic acid serves as a valuable chemical probe for pharmacological studies and a potential starting point for the semi-synthesis of novel therapeutic agents targeting inflammation and cancer. Its isolation and characterization contribute to the field of natural product chemistry and drug discovery.